Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
gout
Fierce Pharma
FDA snubs Sobi’s gout drug over manufacturing issues
The FDA cited deficiencies at a contract manufacturing facility and is requiring additional data related to manufacturing control strategy.
Angus Liu
Jun 29, 2026 11:04am
Sobi pays $950M upfront to snap up gout specialist Arthrosi
Dec 15, 2025 8:15am
Novo drops oncology ambitions, early-stage MASH prospects
Nov 5, 2025 7:21am
Arthrosi raises $153M, fueling dash toward phase 3 gout data
Oct 8, 2025 10:15am
Novo Holdings-backed biotech raises $205M to fill gout care gap
Sep 30, 2025 8:00am
Atom claims ph. 3 win shows gout drug can beat competition
Sep 8, 2025 9:01am
